Umar Aqeel, Hocking Jeffrey, Massin Sophia Z, Suszko Adrian, Wintersperger Bernd J, Chauhan Vijay S
Department of Medical Imaging, University Health Network, Toronto, Ontario, Canada.
Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada.
J Cardiovasc Electrophysiol. 2025 Feb;36(2):489-500. doi: 10.1111/jce.16566. Epub 2025 Jan 5.
Epicardial adipose tissue (EAT) is often associated with atrial fibrosis, and both can provide the substrate for atrial fibrillation (AF). However, most AF patients have no evidence of left atrial (LA) fibrosis based on bipolar voltage mapping. We determined whether EAT differs in AF patients without LA fibrosis compared to matched controls without AF.
Patients undergoing cardiac CT before first-time AF catheter ablation were prospectively enrolled. LA bipolar voltage mapping was performed, and patients were divided into -LVZ (LA low voltage zones < 5% of LA surface area; no fibrosis) and +LVZ (LA low voltage zones ≥ 5%; fibrosis). A control group without AF was matched to -LVZ patients. EAT was quantified on CT using standard signal thresholding to quantify total and regional volumes. AF patients were followed for 1-year postablation to assess atrial arrhythmia (AA) recurrence.
-LVZ (n = 50) had higher total EAT volumes than matched controls (n = 48) (79 [58-109] vs. 51 [37-73] cm³, p < 0.001), higher LA EAT (9 [6.3-12] vs. 4.2 [2.9-5.8] cm³, p < 0.001), higher posterior LA EAT (9.7 [6.4-12] vs. 5.9 [2.8-7.2] cm³, p < 0.001) and higher right atrial EAT (7.3 [5.1-9.9] vs. 4.8 [3.2-6.5] cm³, p < 0.001). These differences remained even after correcting EAT for BMI and LA volumes. There were no significant differences in EAT volumes between -LVZ and +LVZ (n = 25). There was no significant association between EAT and AF recurrence postablation.
EAT volume is greater in AF patients without evidence of LA fibrosis compared to matched controls without AF. These findings support an association of EAT with AF pathogenesis even in the absence of LA fibrosis.
心外膜脂肪组织(EAT)常与心房纤维化相关,两者均可为房颤(AF)提供病理基础。然而,根据双极电压标测,大多数房颤患者并无左心房(LA)纤维化的证据。我们比较了无LA纤维化的房颤患者与无房颤的匹配对照者之间EAT是否存在差异。
前瞻性纳入首次行房颤导管消融术前接受心脏CT检查的患者。进行LA双极电压标测,并将患者分为-LVZ组(LA低电压区<LA表面积的5%;无纤维化)和+LVZ组(LA低电压区≥5%;有纤维化)。将无房颤的对照组与-LVZ组患者进行匹配。在CT上使用标准信号阈值法对EAT进行定量,以量化总体积和局部体积。对房颤患者在消融术后随访1年,以评估房性心律失常(AA)复发情况。
-LVZ组(n = 50)的EAT总体积高于匹配对照组(n = 48)(79 [58 - 109] vs. 51 [37 - 73] cm³,p < 0.001),LA的EAT体积更高(9 [6.3 - 12] vs. 4.2 [2.9 - 5.8] cm³,p < 0.001),LA后壁的EAT体积更高(9.7 [6.4 - 12] vs. 5.9 [2.8 - 7.2] cm³,p < 0.001),右心房的EAT体积更高(7.3 [5.1 - 9.9] vs. 4.8 [3.2 - 6.5] cm³,p < 0.001)。即使在对EAT进行BMI和LA体积校正后,这些差异仍然存在。-LVZ组和+LVZ组(n = 25)之间的EAT体积无显著差异。EAT与消融术后房颤复发之间无显著关联。
与无房颤的匹配对照者相比,无LA纤维化证据的房颤患者的EAT体积更大。这些发现支持即使在无LA纤维化的情况下,EAT也与房颤发病机制相关。